Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Treatment.com International ( (TSE:TRUE) ) has issued an announcement.
Treatment.com AI Inc. has announced a binding letter of intent to acquire Alea Health Holdings Limited. This strategic acquisition will enhance Treatment.com’s platform by integrating Alea Health’s AI-powered voice agent and mental health solutions, allowing the company to expand its geographic reach into the Middle East healthcare market and strengthen its position in AI-driven healthcare innovation.
More about Treatment.com International
Treatment.com AI Inc. operates in the healthcare industry, focusing on delivering innovative AI solutions to enhance healthcare delivery. Their offerings include advanced technologies for patient intake, triage, and mental health support, with a market focus on expanding AI-driven healthtech capabilities.
YTD Price Performance: 37.58%
Average Trading Volume: 5,689
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $23.16M
For detailed information about TRUE stock, go to TipRanks’ Stock Analysis page.
